Impact Analysis of Covid-19

The complete version of the REPORT will include the impact of the COVID-19, and anticipated change on the future outlook of the industry, by taking into the account the political, economic, social, and technological parameters.

Regenerative Therapies Market – Insights

Regenerative therapies deliver specific types of cells or cell products to diseased tissues or organs to restore tissue and organ function. Materials used in regenerative therapies release growth factors and cytokines back into the damaged tissue to aid the healing process.

The global regenerative therapies market is estimated to account for US$ 10,421.5 Mn in terms of value in 2019 and is expected to reach US$ 45,940.7 Mn by the end of 2027

Global Regenerative Therapies Market: Drivers

Increasing prevalence of cardiovascular diseases (CVDs) is expected to propel growth of the global regenerative therapies market over the forecast period. For instance, according to the American Heart Association's Heart and Stroke Statistics 2019 Update, around 48% of all adults in the U.S. suffered from some type of CVD in 2016.

Moreover, increasing focus on tissue-cell and stem cell research is also expected to aid in growth of the market. For instance, in March 2020, researchers from Dankook University and Catholic University, South Korea, reported investigation of the types and degrees of physical and psychological discomfort experienced by hematopoietic stem cell donors before, during, and after the donation process.

Allograft held dominant position in the global regenerative therapies market in 2019, accounting for 57.7% share in terms of value, followed by xenograft and alloplast, respectively.

Regenerative Therapies  | Coherent Market Insights

Global Regenerative Therapies Market: Restraints

Lack of standardized guidelines on tissue and bio-medical engineering is expected to hinder growth of the global regenerative therapies market. Lack of standardized guidelines on biomedical and tissue engineering and stem-cell research across regions is hampering production and approval of regenerative therapies. This in turn increases cost burden of regulatory approval for product makers.

Moreover, high gestation period and time-to-market due to lengthy clinical trials is also expected to limit growth of the market. A prime pitfall in development of new innovative regenerative therapies is lengthy clinical trial process. The process becomes lengthy due to acute dearth in availability of clinical trial subjects, who usually do not want to participate in such trials. Long gestation period often leads to abandonment of clinical trials midway, creating both financial as well as loss of ideas.

Global Regenerative Therapies Market: Opportunities 

Development of new regenerative techniques is expected to offer lucrative growth opportunities for players in the market. For instance, simple hip decompression is a new regenerative technique for patients with early-stage osteonecrosis of the hip. It is a less invasive outpatient procedure in which a surgeon makes a small hole outside the hip and taps into the diseased area.

Adoption of 3D printing technology in regenerative therapies is expected to aid in growth of the market. For instance, in February 2020, researchers from Wake Forest School of Medicine, U.S. reported investigation of the effects of neural cell integration into the bioprinted skeletal muscle construct to accelerate functional muscle regeneration in vivo.

Regenerative Therapies  | Coherent Market Insights

Market Trends/Key Takeaways

In the U.S., the prevalence of cancer is increasing, thereby aiding in growth of the market. For instance, according to the American Cancer Society, in 2019, there will be an estimated 1,762,450 new cancer cases diagnosed and 606,880 cancer deaths in the U.S.

Regenerative therapies are used for the treatment of various skin diseases. For instance, in March 2020, RenovaCare, Inc., a developer of patented technologies for spraying self-donated stem cells for the regeneration of skin and other organs and tissues, announced that its SkinGun is being used to apply regenerative cells in a preclinical study of new gene therapies, underway at King’s College London.

Regulations

U.S.

HCT/Ps – Two Regulatory Tiers

Tissue (“361 HCT/P”)

  • Section 361 of PHS Act
  • Premarket review and approval not required; Product regulated solely under Tissue Regulations to control communicable disease (21 CRF 1271)
  • Establishment registration and product listing required (21 CRF 1271 -Subpart B)

Therapeutic (“351 HCT/P”)

  • Sections 351 and 361 of PHS Act, FD and C Act
  • Product regulated under Tissue Regulations and premarket review requirements (21 CFR Parts 1271, 600, 200, 312, 812(if device))
  • Regulatory path: can be BIOLOGIC or DEVICE

Value Chain Analysis

Regenerative Therapies  | Coherent Market Insights

Global Regenerative Therapies Market: Competitive Landscape  

Major players operating in the global regenerative therapies market include, Shire Pharmaceuticals, Kinetic Concepts, Inc., Mesoblast Ltd., Nuo Therapeutics (Cytomedix Inc.), Advanced Cell Technology, Inc., BioStem Life Sciences, Akron Biotechnology, LLC, Organovo Holdings Inc., Orgenesis Inc., Pluristem Therapeutics Inc., Genzyme, Athersys, Inc., RenovaCare, Inc., and Cytori Therapeutics, Inc.

Global Regenerative Therapies Market: Competitive Landscape  

Major players in the market are also focused on expanding their capabilities. For instance, in March 2020, Akron Biotechnology, LLC announced its expansion to a second manufacturing facility in the US.

Major players in the market are also focused on adopting collaboration strategies to expand their product portfolio. For instance, in March 2020, Pluristem Therapeutics Inc. collaborated with the BIH Center for Regenerative Therapy (BCRT) and the Berlin Center for Advanced Therapies (BeCAT) at Charite’ University of Medicine Berlin for R&D in potential treatment for respiratory and inflammatory intratissue complications caused by covid-19.

Regenerative medicine is one the fastest emerging fields of medicine, as it adopts stem cells for treatment. Increasing age or injury, makes it difficult to provide the optimum amount of stem cells that are needed to maintain the normal function. The goal of regenerative medicine is to amplify this natural repair system to keep pace with the demands of the patients. Orthopedics is one of the fields of regenerative medicine, which adopts natural healing process by stimulating regeneration of cells in the musculoskeletal system. Histogen Inc. is one of the manufacturer of orthopedic regenerative medicine and its product Human Extracellular matrix (hECM) is anti-inflammatory, angiogenic, and can stimulate growth of stem cells in damaged areas to induce tissue regeneration.

Restraints of the Global Regenerative Therapies Market

Lack of standardized guidelines on tissue and bio-medical engineering is expected to hinder growth of the global regenerative therapies market. Moreover, lengthy clinical trials leading to delayed entry of products in the market is expected to restrain growth of the market.

Key features of the study:

  • This report provides in-depth analysis of the global regenerative therapies market and provides market size (US$ Million) and compound annual growth rate (CAGR %) for the forecast period (2019–2027), considering 2018, as the base year
  • It elucidates potential revenue opportunity across different segments and explains attractive investment proposition matrix for this market
  • This study also provides key insights about market drivers, restraints, opportunities, new product launches or approval, regional outlook, and competitive strategy adopted by leading players
  • It profiles leading players in the global regenerative therapies market based on the following parameters – company overview, financial performance, product portfolio, geographical presence, distribution strategies, key developments, strategies, and future plans
  • Key companies covered as a part of this study include Shire Pharmaceuticals, Kinetic Concepts, Inc., Mesoblast Ltd., Nuo Therapeutics (Cytomedix Inc.), Advanced Cell Technology, Inc., BioStem Life Sciences, Akron Biotechnology, LLC, Organovo Holdings Inc., Orgenesis Inc., Pluristem Therapeutics Inc., Genzyme, Athersys, Inc., RenovaCare, Inc., and Cytori Therapeutics, Inc.
  • Insights from this report would allow marketers and the management authorities of companies to make informed decision regarding future product launches, technology up-gradation, market expansion, and marketing tactics
  • The global regenerative therapies market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts.
  • Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the market.

Detailed Segmentation

  • Global Regenerative Therapies Market, By Tissue Type:
    • Allograft
    • Xenograft
    • Alloplast
  • Global Regenerative Therapies Market, By Application:
    • Soft Tissue Repair
    • Cardiovascular
    • Dental
    • Orthopedic
    • CNS disease treatment
    • Others
  • Global Regenerative Therapies Market, By End User:
    • Hospitals
    • Ambulatory Surgical Centers
    • Educational Institutes
  • Global Regenerative Therapies Market, By Geography:
    • North America
      • By Tissue Type
        • Allograft
        • Xenograft
        • Alloplast
      • By Application
        • Soft Tissue Repair
        • Cardiovascular
        • Dental
        • Orthopedic
        • CNS disease treatment
        • Others
      • By End User
        • Hospitals
        • Ambulatory Surgical Centers
        • Educational Institutes
      • By Country:
        • U.S.
        • Canada
    • Europe
      • By Tissue Type
        • Allograft
        • Xenograft
        • Alloplast
      • By Application
        • Soft Tissue Repair
        • Cardiovascular
        • Dental
        • Orthopedic
        • CNS disease treatment
        • Others
      • By End User
        • Hospitals
        • Ambulatory Surgical Centers
        • Educational Institutes
      • By Country:
        • U.K.
        • Germany
        • Italy
        • France
        • Spain
        • Russia
        • Rest of Europe
    • Asia Pacific
      • By Tissue Type
        • Allograft
        • Xenograft
        • Alloplast
      • By Application
        • Soft Tissue Repair
        • Cardiovascular
        • Dental
        • Orthopedic
        • CNS disease treatment
        • Others
      • By End User
        • Hospitals
        • Ambulatory Surgical Centers
        • Educational Institutes
      • By Country:
        • China
        • India
        • Japan
        • ASEAN
        • Australia
        • South Korea
        • Rest of Asia Pacific
    • Latin America
      • By Tissue Type
        • Allograft
        • Xenograft
        • Alloplast
      • By Application
        • Soft Tissue Repair
        • Cardiovascular
        • Dental
        • Orthopedic
        • CNS disease treatment
        • Others
      • By End User
        • Hospitals
        • Ambulatory Surgical Centers
        • Educational Institutes
      • By Country:
        • Brazil
        • Mexico
        • Argentina
        • Rest of Latin America
    • Middle East:
      • By Tissue Type
        • Allograft
        • Xenograft
        • Alloplast
      • By Application
        • Soft Tissue Repair
        • Cardiovascular
        • Dental
        • Orthopedic
        • CNS disease treatment
        • Others
      • By End User
        • Hospitals
        • Ambulatory Surgical Centers
        • Educational Institutes
      • By Country:
        • GCC
        • Israel
        • Rest of Middle East
    • Africa
      • By Tissue Type
        • Allograft
        • Xenograft
        • Alloplast
      • By Application
        • Soft Tissue Repair
        • Cardiovascular
        • Dental
        • Orthopedic
        • CNS disease treatment
        • Others
      • By End User
        • Hospitals
        • Ambulatory Surgical Centers
        • Educational Institutes
      • By Country/Region:
        • Central Africa
        • South Africa
        • North Africa
  • Company Profiles
    • Shire Pharmaceuticals *
      • Company Overview
      • Product Portfolio
      • Financial Performance
      • Key Strategies
      • Recent Developments
    • Kinetic Concepts, Inc.
    • Mesoblast Ltd.
    • Nuo Therapeutics (Cytomedix Inc.)
    • Advanced Cell Technology, Inc.
    • BioStem Life Sciences
    • Akron Biotechnology, LLC
    • Organovo Holdings Inc.
    • Orgenesis Inc.
    • Pluristem Therapeutics Inc.
    • Genzyme
    • Athersys, Inc.
    • RenovaCare, Inc.
    • Cytori Therapeutics, Inc.

 “*” marked represents similar segmentation in other categories in the respective section.

Table of Contents

  1. Research Objective and Assumption
    • Research Objectives
    • Assumptions
    • Abbreviations
  2. Market Purview
    • Report Description
      • Market Definition and Scope
    • Executive Summary
      • Market Snippet, By Tissue Type
      • Market Snippet, By Application
      • Market Snippet, By End User
    • Coherent Opportunity Map (COM)
  3. Market Dynamics, Regulations, and Trends Analysis
    • Market Dynamics
      • Drivers
      • Restraints
      • Market Opportunities
    • Impact Analysis
    • Key Developments
    • Regulatory Scenario
    • PEST Analysis
  4. Global Regenerative Therapies Market, By Tissue Type, 2019 – 2027 (US$ Mn)
    • Introduction
      • Market Share Analysis, 2019 and 2027 (%)
      • Y-o-Y Growth Analysis, 2017–2027
      • Segment Trends
    • Allograft
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2016 – 2027, (US$ Mn)
      • Segment Trends
    • Xenograft
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2016 – 2027, (US$ Mn)
      • Segment Trends
    • Alloplast
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2016 – 2027, (US$ Mn)
      • Segment Trends
  5. Global Regenerative Therapies Market, By Application, 2019 – 2027 (US$ Mn)
    • Introduction
      • Market Share Analysis, 2019 and 2027 (%)
      • Y-o-Y Growth Analysis, 2017–2027
      • Segment Trends
    • Soft Tissue Repair
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2016 – 2027, (US$ Mn)
    • Cardiovascular
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2016 – 2027, (US$ Mn)
    • Dental
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2016 – 2027, (US$ Mn)
    • Orthopedic
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2016 – 2027, (US$ Mn)
    • CNS disease treatment
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2016 – 2027, (US$ Mn)
    • Others
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2016 – 2027, (US$ Mn)
  6. Global Regenerative Therapies Market, By End User, 2019 – 2027 (US$ Mn)
    • Introduction
      • Market Share Analysis, 2019 and 2027 (%)
      • Y-o-Y Growth Analysis, 2017–2027
      • Segment Trends
    • Hospitals
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2016 – 2027, (US$ Mn)
    • Ambulatory Surgical Centers
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2016 – 2027, (US$ Mn)
    • Educational Institutes
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2016 – 2027, (US$ Mn)
  7. Global Regenerative Therapies Market, By Regions, 2019 – 2027 (US$ Mn)
    • Introduction
      • Market Share Analysis, 2019 and 2027 (%)
      • Y-o-Y Growth Analysis, 2017–2027
      • Segment Trends
    • North America
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2016 – 2027, (US$ Mn)
        • U.S.
        • Canada
    • Europe
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2016 – 2027, (US$ Mn)
        • U.K.
        • Germany
        • Italy
        • France
        • Spain
        • Russia
        • Rest of Europe
    • Asia Pacific
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2016 – 2027, (US$ Mn)
        • China
        • India
        • Japan
        • ASEAN
        • Australia
        • South Korea
        • Rest of Asia Pacific
    • Latin America
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2016 – 2027, (US$ Mn)
        • Brazil
        • Mexico
        • Argentina
        • Rest of Latin America
    • Middle East
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2016 – 2027, (US$ Mn)
        • GCC
        • Israel
        • Rest of Middle East
    • Africa
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2016 – 2027, (US$ Mn)
        • North Africa
        • Central Africa
        • South Africa
  8. Competitive Landscape
    • Company Profiles
      • Shire Pharmaceuticals
        • Company Overview
        • Product Portfolio
        • Key Developments
        • Financial Performance
        • Strategies
      • Kinetic Concepts, Inc.
        • Company Overview
        • Product Portfolio
        • Key Developments
        • Financial Performance
        • Strategies
      • Mesoblast Ltd.
        • Company Overview
        • Product Portfolio
        • Key Developments
        • Financial Performance
        • Strategies
      • Nuo Therapeutics (Cytomedix Inc.)
        • Company Overview
        • Product Portfolio
        • Key Developments
        • Financial Performance
        • Strategies
      • Advanced Cell Technology, Inc.
        • Company Overview
        • Product Portfolio
        • Key Developments
        • Financial Performance
        • Strategies
      • BioStem Life Sciences
        • Company Overview
        • Product Portfolio
        • Key Developments
        • Financial Performance
        • Strategies
      • Akron Biotechnology, LLC
        • Company Overview
        • Product Portfolio
        • Key Developments
        • Financial Performance
        • Strategies
      • Organovo Holdings Inc.
        • Company Overview
        • Product Portfolio
        • Key Developments
        • Financial Performance
        • Strategies
      • Orgenesis Inc.
        • Company Overview
        • Product Portfolio
        • Key Developments
        • Financial Performance
        • Strategies
      • Pluristem Therapeutics Inc.
        • Company Overview
        • Product Portfolio
        • Key Developments
        • Financial Performance
        • Strategies
      • Genzyme
        • Company Overview
        • Product Portfolio
        • Key Developments
        • Financial Performance
        • Strategies
      • Athersys, Inc.
        • Company Overview
        • Product Portfolio
        • Key Developments
        • Financial Performance
        • Strategies
      • RenovaCare, Inc.
        • Company Overview
        • Product Portfolio
        • Key Developments
        • Financial Performance
        • Strategies
      • Cytori Therapeutics, Inc.
        • Company Overview
        • Product Portfolio
        • Key Developments
        • Financial Performance
        • Strategies
  9. Section
    • References
    • Research Methodology
    • About us and Sales Contact

*Browse 31 market data tables and 23 figures on “Regenerative Therapies Market – Global forecast to 2027.

Frequently Asked Questions

This report provides in-depth analysis of the global regenerative therapies market and provides market size (US$ Mn) and compound annual growth rate (CAGR) (%) for the forecast period (2019 – 2027). The report also provides also provides valuable insights about market drivers, restraints, opportunities, country outlook, and competitive strategies adopted by the leading players.
Key segments covered in the report include: o By Tissue Type o By Application o By End User o By Region
The report provides also provides valuable insights about market drivers, restraints, opportunities, country outlook, and competitive strategies adopted by the leading players.
The report profiles leading players in the global regenerative therapies based on the following parameters – company overview, financial performance, product portfolio, geographical presence, key developments, and future plans.
Existing Clientele

Joining thousands of companies around the world committed to making the Excellent Business Solutions.

View All Our Clients

Our Trusted Patner